Schedule 13G ownership disclosure

Verastem Inc

Common Stock, $0.0001 par value per share · CUSIP: 92337C203

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOTECHNOLOGY VALUE FUND L P

    Shares: 3,244,310.00 · Class: 5.8%

  • BVF I GP LLC

    Shares: 3,244,310.00 · Class: 5.8%

  • BIOTECHNOLOGY VALUE FUND II LP

    Shares: 2,173,798.00 · Class: 3.9%

  • BVF II GP LLC

    Shares: 2,173,798.00 · Class: 3.9%

  • Biotechnology Value Trading Fund OS LP

    Shares: 214,663.00 · Class: 0.4%

  • BVF Partners OS Ltd.

    Shares: 214,663.00 · Class: 0.4%

  • BVF GP HOLDINGS LLC

    Shares: 5,418,108.00 · Class: 9.5%

  • BVF PARTNERS L P/IL

    Shares: 5,720,831.00 · Class: 9.99%

  • BVF INC/IL

    Shares: 5,720,831.00 · Class: 9.99%

  • LAMPERT MARK N

    Shares: 5,720,831.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-002213
Form type
SCHEDULE 13G/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Aug 13, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub